Literature DB >> 26082285

QUANTITATIVE PLANAR AND VOLUMETRIC CARDIAC MEASUREMENTS USING 64 MDCT AND 3T MRI VS. STANDARD 2D AND M-MODE ECHOCARDIOGRAPHY: DOES ANESTHETIC PROTOCOL MATTER?

Randi Drees1, Rebecca A Johnson1, Rebecca L Stepien2, Alejandro Munoz Del Rio3, Jimmy H Saunders4, Christopher J François5.   

Abstract

Cross-sectional imaging of the heart utilizing computed tomography and magnetic resonance imaging (MRI) has been shown to be superior for the evaluation of cardiac morphology and systolic function in humans compared to echocardiography. The purpose of this prospective study was to test the effects of two different anesthetic protocols on cardiac measurements in 10 healthy beagle dogs using 64-multidetector row computed tomographic angiography (64-MDCTA), 3T magnetic resonance (MRI) and standard awake echocardiography. Both anesthetic protocols used propofol for induction and isoflourane for anesthetic maintenance. In addition, protocol A used midazolam/fentanyl and protocol B used dexmedetomedine as premedication and constant rate infusion during the procedure. Significant elevations in systolic and mean blood pressure were present when using protocol B. There was overall good agreement between the variables of cardiac size and systolic function generated from the MDCTA and MRI exams and no significant difference was found when comparing the variables acquired using either anesthetic protocol within each modality. Systolic function variables generated using 64-MDCTA and 3T MRI were only able to predict the left ventricular end diastolic volume as measured during awake echocardiogram when using protocol B and 64-MDCTA. For all other systolic function variables, prediction of awake echocardiographic results was not possible (P = 1). Planar variables acquired using MDCTA or MRI did not allow prediction of the corresponding measurements generated using echocardiography in the awake patients (P = 1). Future studies are needed to validate this approach in a more varied population and clinically affected dogs.
© 2015 American College of Veterinary Radiology.

Entities:  

Keywords:  cardiac function; cardiac size; computed tomography; dog; magnetic resonance imaging

Mesh:

Substances:

Year:  2015        PMID: 26082285      PMCID: PMC5006684          DOI: 10.1111/vru.12269

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  65 in total

1.  The effect of midazolam on the end-tidal concentration of isoflurane necessary to prevent movement in dogs.

Authors:  Reza Seddighi; Christine M Egger; Barton W Rohrbach; Sherry K Cox; Thomas J Doherty
Journal:  Vet Anaesth Analg       Date:  2011-05       Impact factor: 1.648

2.  Comparative assessment of left ventricular function variables determined via cardiac computed tomography and cardiac magnetic resonance imaging in dogs.

Authors:  Anne K Sieslack; Peter Dziallas; Ingo Nolte; Patrick Wefstaedt
Journal:  Am J Vet Res       Date:  2013-07       Impact factor: 1.156

Review 3.  [State of the art: new developments in cardiac imaging].

Authors:  José F Forteza Albertí; José J Gómez de Diego; Ricardo Vivancos Delgado; Jaume Candell Riera; Río Aguilar Torres
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2012-01

4.  Validation of MRI measurement of cardiac output in the dog: the effects of dobutamine and minoxidil.

Authors:  Paul D Hockings; Albert L Busza; Joanne Byrne; Bela Patel; Sean C Smart; David G Reid; Heather L Lloyd; Alan White; Karen Pointing; Belinda A Farnfield; Ana Criado-Gonzalez; Greg A Whelan; Gemma L Taylor; Jeffrey M Birmingham; Mark R Slaughter; Janette A Osborne; Axel Krebs-Brown; David Templeton
Journal:  Toxicol Mech Methods       Date:  2003       Impact factor: 2.987

5.  Cardiac magnetic resonance imaging in normal dogs and two dogs with heart base tumor.

Authors:  Wilfried Mai; Chick Weisse; Meg M Sleeper
Journal:  Vet Radiol Ultrasound       Date:  2010 Jul-Aug       Impact factor: 1.363

6.  [Computer tomographic differentiation of intrathoracic neoplasms and inflammation in the dog].

Authors:  Simone Schuller; Mathilde Fredericksen; Heike Schröder; Andrea Meyer-Lindenberg; Marion Hewicker-Trautwein; Ingo Nolte
Journal:  Berl Munch Tierarztl Wochenschr       Date:  2005 Jan-Feb       Impact factor: 0.328

7.  Cardiovascular, respiratory, electrolyte and acid-base balance during continuous dexmedetomidine infusion in anesthetized dogs.

Authors:  Jonathan M Congdon; Megan Marquez; Sirirat Niyom; Pedro Boscan
Journal:  Vet Anaesth Analg       Date:  2013-04-15       Impact factor: 1.648

8.  Comparison of accuracy of axial slices versus short-axis slices for measuring ventricular volumes by cardiac magnetic resonance in patients with corrected tetralogy of fallot.

Authors:  Sohrab Fratz; Annika Schuhbaeck; Christine Buchner; Raymonde Busch; Christian Meierhofer; Stefan Martinoff; John Hess; Heiko Stern
Journal:  Am J Cardiol       Date:  2009-05-04       Impact factor: 2.778

9.  Dexmedetomidine constant rate infusion for 24 hours during and after propofol or isoflurane anaesthesia in dogs.

Authors:  Guan-Yu Lin; Joris H Robben; Joanna C Murrell; John Aspegrén; Brett C McKusick; Ludo J Hellebrekers
Journal:  Vet Anaesth Analg       Date:  2008-01-04       Impact factor: 1.648

10.  Accurate quantification of right ventricular mass at MR imaging by using cine true fast imaging with steady-state precession: study in dogs.

Authors:  Stephanie M Shors; Carina W Fung; Christopher J François; J Paul Finn; David S Fieno
Journal:  Radiology       Date:  2003-12-29       Impact factor: 11.105

View more
  2 in total

1.  Contrast Echocardiography in two-dimensional left ventricular measurements: comparison with 256-row multi-detector computed tomography as a reference standard in Beagles.

Authors:  Jaehwan Kim; Soyoung Kim; Yeonhea Lee; Hakyoung Yoon; Kidong Eom
Journal:  J Vet Sci       Date:  2019-09       Impact factor: 1.672

2.  Joint virtual issue on recent advances in veterinary cardiac imaging.

Authors:  Brian A Scansen; Randi Drees
Journal:  J Vet Intern Med       Date:  2020-01-15       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.